- Home
- ADXN vs ACON Comparison
ADXN vs ACON Comparison
Compare ADXN & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- ACON
- Stock Information
- Founded
- ADXN 2002
- ACON 2008
- Country
- ADXN Switzerland
- ACON United States
- Employees
- ADXN N/A
- ACON N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- ADXN Health Care
- ACON Technology
- Exchange
- ADXN Nasdaq
- ACON Nasdaq
- Market Cap
- ADXN 8.2M
- ACON 7.1M
- IPO Year
- ADXN N/A
- ACON 2022
- Fundamental
- Price
- ADXN $7.45
- ACON $12.61
- Analyst Decision
- ADXN Strong Buy
- ACON Buy
- Analyst Count
- ADXN 1
- ACON 2
- Target Price
- ADXN $30.00
- ACON $481.00
- AVG Volume (30 Days)
- ADXN 7.7K
- ACON 370.3K
- Earning Date
- ADXN 04-07-2025
- ACON 05-14-2025
- Dividend Yield
- ADXN N/A
- ACON N/A
- EPS Growth
- ADXN N/A
- ACON N/A
- EPS
- ADXN 0.06
- ACON N/A
- Revenue
- ADXN $701,260.00
- ACON $49,289.00
- Revenue This Year
- ADXN N/A
- ACON N/A
- Revenue Next Year
- ADXN N/A
- ACON $186.36
- P/E Ratio
- ADXN $0.89
- ACON N/A
- Revenue Growth
- ADXN N/A
- ACON N/A
- 52 Week Low
- ADXN $6.67
- ACON $9.75
- 52 Week High
- ADXN $27.90
- ACON $6,241.05
- Technical
- Relative Strength Index (RSI)
- ADXN 47.90
- ACON 33.96
- Support Level
- ADXN $7.16
- ACON $9.75
- Resistance Level
- ADXN $8.05
- ACON $15.08
- Average True Range (ATR)
- ADXN 0.45
- ACON 3.14
- MACD
- ADXN -0.02
- ACON 12.50
- Stochastic Oscillator
- ADXN 51.22
- ACON 13.43
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.